Triple-negative breast cancer (TNBC) is a heterogeneous group of breast cancers characterized by the loss of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) gene expression (70). Here, ERBB2 is linked to breast cancer.